HIN-1 and the nosology of breast cancer

Cancer Biology and Therapy

Volumn 2, Issue 5, 2003, Pages 564-565

  Silver, Daniel P ^a  

^a NONE

Author keywords

Basal; BRCA1; Breast cancer; Medullary

Indexed keywords

CYTOKINE; SCGB3A1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

BREAST TUMOR; DNA METHYLATION; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MEDULLARY CARCINOMA; MUTATION; NOTE; PAGET NIPPLE DISEASE; PATHOLOGY; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL; CARCINOMA, MEDULLARY; CYTOKINES; DNA METHYLATION; FEMALE; GENES, BRCA1; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; TUMOR SUPPRESSOR PROTEINS;

EID: 1542682247     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.2.5.512     Document Type: Note

References (18)

1. Page DL. Special types of invasive breast cancer, with clinical implications. Am J Surg Pathol 2003; 27:832-5. (Pubitemid 36617522)
2. Beatson GT. On the treatment of inoperable cases of carcinoma of the mammary. Suggestions for a new method of treatment with illustrative cases. Lancet 1896. 2:104-7, 162-5.
3. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235:177-82. (Pubitemid 17231334)
4. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003; 100:8418-23. (Pubitemid 36842560)
5. Porter DA, Krop IE, Nasser S, Sgroi D, Kaelin CM, Marks JR, et al. A SAGE (serial analysis of gene expression) view of breast tumor progression. Cancer Res 2001; 61:5697-702.
6. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-52.
7. West, M., et al., Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 2001; 98:11462-7.
8. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-6.
9. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98:10869-74. (Pubitemid 32878711)
10. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 2003; Epub.
11. Ridolfi RL, Rosen PP, Port A, Kinne D, Mike V. Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer 1977; 40:1365-85. (Pubitemid 8221704)
12. Rapin V, Contesso G, Mouriesse H, Bertin F, Lacombe MJ, Piekarski JD, et al. Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer 1988; 61:2503-10.
13. Eisinger F, Jacquemier J, Charpin C, Stoppa-Lyonnet D, Bressac-de Paillerets B, Peyrat JP, et al. Mutations at BRCA1: the medullary breast carcinoma revisited. Cancer Res 1998; 58:1588-92. (Pubitemid 28215075)
14. Breast Cancer Linkage Consortium. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 1997 349:1505-10.
15. Krop IE, Sgroi D, Porter DA, Lunetta KL, LeVangie R, Seth P, et al. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Proc Natl Acad Sci USA 2001; 98:9796-801. (Pubitemid 32769383)
16. Krop I, Maguire P, Lahti-Domenici J, Lodeiro G, Richardson A, Johannsdottir HK, et al. Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors. Cancer Res 2003; 63:2024-7. (Pubitemid 36538601)
17. Ganesan S, Silver DP, Greenberg RA, Avni D, Drapkin R, Miron A, et al. BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell 2002; 111:393-405. (Pubitemid 35341392)
18. Archey WB, McEachern KA, Robson M, Offit K, Vaziri SA, Casey G, et al. Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers. Oncogene 2002; 21:7034-41. (Pubitemid 35252977)